Permanent facial hypopigmentation following treatment with imiquimod cream.
Mendonça
C O
CO
Yates
V M
VM
D000368:Aged; D000634:Aminoquinolines / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000150:complications / Q000188:drug therapy*; D005153:Facial Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced*; D000077271:Imiquimod; D008297:Male; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D013256:Steroids; D000077271:Imiquimod